All lobbying filings

BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)

Lobbying for BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $190,000.00 expenses · posted Apr 21, 2025

Official filing document

Bills named in this filing 5

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
HR 919
Chronic Disease Flexible Coverage Act
HR 1539
Medical Device Electronic Labeling Act
S 317
Charitable Act
HR 801
Charitable Act

Lobbying activity 3

Budget/Appropriations

Issues pertaining to NIH research funding H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025

Health Issues

Issues pertaining to NIH research funding Issues pertaining to Medicare coverage of AID and CGM systems H.R. 919, the Chronic Disease Flexible Coverage Act H.R. 1539, the Medical Device Electronic Labeling Act

Taxation/Internal Revenue Code

S. 317 / H.R. 801, The Charitable Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.